389 related articles for article (PubMed ID: 24289611)
41. Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2.
Morse MA; Hobeika A; Osada T; Niedzwiecki D; Marcom PK; Blackwell KL; Anders C; Devi GR; Lyerly HK; Clay TM
J Transl Med; 2007 Sep; 5():42. PubMed ID: 17822557
[TBL] [Abstract][Full Text] [Related]
42. Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer.
Mittendorf EA; Gurney JM; Storrer CE; Shriver CD; Ponniah S; Peoples GE
Surgery; 2006 Mar; 139(3):407-18. PubMed ID: 16546506
[TBL] [Abstract][Full Text] [Related]
43. Metadherin peptides containing CD4(+) and CD8(+) T cell epitopes as a therapeutic vaccine candidate against cancer.
Dhiman G; Lohia N; Jain S; Baranwal M
Microbiol Immunol; 2016 Sep; 60(9):646-52. PubMed ID: 27554419
[TBL] [Abstract][Full Text] [Related]
44. In silico prediction of potential vaccine candidates on capsid protein of human bocavirus 1.
Kalyanaraman N
Mol Immunol; 2018 Jan; 93():193-205. PubMed ID: 29207326
[TBL] [Abstract][Full Text] [Related]
45. Computational analysis in designing T cell epitopes enriched peptides of Ebola glycoprotein exhibiting strong binding interaction with HLA molecules.
Jain S; Baranwal M
J Theor Biol; 2019 Mar; 465():34-44. PubMed ID: 30639295
[TBL] [Abstract][Full Text] [Related]
46. [Anti-HER2 vaccines: The HER2 immunotargeting future?].
Ladjemi MZ; Jacot W; Pèlegrin A; Navarro-Teulon I
Pathol Biol (Paris); 2011 Jun; 59(3):173-82. PubMed ID: 19481373
[TBL] [Abstract][Full Text] [Related]
47. In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma.
Safavi A; Kefayat A; Abiri A; Mahdevar E; Behnia AH; Ghahremani F
Mol Immunol; 2019 Aug; 112():93-102. PubMed ID: 31079006
[TBL] [Abstract][Full Text] [Related]
48. A common conserved peptide harboring predicted T and B cell epitopes in domain III of envelope protein of Japanese Encephalitis Virus and West Nile Virus for potential use in epitope based vaccines.
Slathia PS; Sharma P
Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():238-245. PubMed ID: 31300121
[TBL] [Abstract][Full Text] [Related]
49. A novel method for enhancement of peptide vaccination utilizing T-cell epitopes from conventional vaccines.
Yano A; Miwa Y; Kanazawa Y; Ito K; Makino M; Imai S; Hanada N; Nisizawa T
Vaccine; 2013 Mar; 31(11):1510-5. PubMed ID: 23318151
[TBL] [Abstract][Full Text] [Related]
50. A Therapeutic Her2/neu Vaccine Targeting Dendritic Cells Preferentially Inhibits the Growth of Low Her2/neu-Expressing Tumor in HLA-A2 Transgenic Mice.
Tran T; Diniz MO; Dransart E; Gey A; Merillon N; Lone YC; Godefroy S; Sibley C; Ferreira LC; Medioni J; Oudard S; Johannes L; Tartour E
Clin Cancer Res; 2016 Aug; 22(16):4133-44. PubMed ID: 27006496
[TBL] [Abstract][Full Text] [Related]
51. Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach.
Oany AR; Emran AA; Jyoti TP
Drug Des Devel Ther; 2014; 8():1139-49. PubMed ID: 25187696
[TBL] [Abstract][Full Text] [Related]
52. Mapping T and B cell epitopes in sperm protein 17 to support the development of an ovarian cancer vaccine.
Xiang SD; Gao Q; Wilson KL; Heyerick A; Plebanski M
Vaccine; 2015 Nov; 33(44):5950-9. PubMed ID: 26263201
[TBL] [Abstract][Full Text] [Related]
53. Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice.
Lin SI; Huang MH; Chang YW; Chen IH; Roffler S; Chen BM; Sher YP; Liu SJ
Cancer Lett; 2016 Jul; 377(2):126-33. PubMed ID: 27130449
[TBL] [Abstract][Full Text] [Related]
54. Comparative analysis of evolutionarily conserved motifs of epidermal growth factor receptor 2 (HER2) predicts novel potential therapeutic epitopes.
Deng X; Zheng X; Yang H; Moreira JM; Brünner N; Christensen H
PLoS One; 2014; 9(9):e106448. PubMed ID: 25192037
[TBL] [Abstract][Full Text] [Related]
55. Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope.
Sotiriadou R; Perez SA; Gritzapis AD; Sotiropoulou PA; Echner H; Heinzel S; Mamalaki A; Pawelec G; Voelter W; Baxevanis CN; Papamichail M
Br J Cancer; 2001 Nov; 85(10):1527-34. PubMed ID: 11720440
[TBL] [Abstract][Full Text] [Related]
56. HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan.
Kitano S; Kageyama S; Nagata Y; Miyahara Y; Hiasa A; Naota H; Okumura S; Imai H; Shiraishi T; Masuya M; Nishikawa M; Sunamoto J; Akiyoshi K; Kanematsu T; Scott AM; Murphy R; Hoffman EW; Old LJ; Shiku H
Clin Cancer Res; 2006 Dec; 12(24):7397-405. PubMed ID: 17189412
[TBL] [Abstract][Full Text] [Related]
57. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
[TBL] [Abstract][Full Text] [Related]
58. Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches.
Mahdevar E; Safavi A; Abiri A; Kefayat A; Hejazi SH; Miresmaeili SM; Iranpur Mobarakeh V
J Biomol Struct Dyn; 2022 Sep; 40(14):6363-6380. PubMed ID: 33599191
[TBL] [Abstract][Full Text] [Related]
59. Generation of populations of antigen-specific cytotoxic T cells using DCs transfected with DNA construct encoding HER2/neu tumor antigen epitopes.
Kuznetsova M; Lopatnikova J; Khantakova J; Maksyutov R; Maksyutov A; Sennikov S
BMC Immunol; 2017 Jun; 18(1):31. PubMed ID: 28633645
[TBL] [Abstract][Full Text] [Related]
60. In silico identification of potential epitopes present in human adenovirus proteins for vaccine design and of putative drugs for treatment against viral infection.
Hossain R; Yasmin T; Hosen MI; Nabi AHMN
J Immunol Methods; 2018 Apr; 455():55-70. PubMed ID: 29371093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
